Ataxin3 active human, recombinant, expressed in E. coli, >=59% (SDS-PAGE)

Code: srp0445-250ug D2-231

Not available outside of the UK & Ireland.

Application

Useful for the study of enzyme kinetics, screening inhibitors, and selectivity profiling.

Biochem/physiol Actions

Ataxin3 (ATXN3) is ...


read more

Your Price
$571.04 250UG

Not available outside of the UK & Ireland.

Application

Useful for the study of enzyme kinetics, screening inhibitors, and selectivity profiling.

Biochem/physiol Actions

Ataxin3 (ATXN3) is a polyglutamine neurodegenerative disease protein involved in the ubiquitin-proteasome pathway. ATXN3 performs all the functions same as ubiquitin proteases such as, reducing polyubiquitylation of 125I-lysozyme by removing ubiquitin from polyubiquitin chains, cleaving a ubiquitin protease substrate and binding the specific ubiquitin protease inhibitor, ubiquitin-aldehyde. Mutation in the gene has been observed in spinocerebellar ataxia type 3 patients.

General description

Ataxin3 (ATXN3) is encoded by the gene mapped to human chromosome 14q32. The encoded protein is characterized with a ubiquitin interaction motif (UIM) domain involved in binding mono and/or polyubiquitylated proteins.

assay≥59% (SDS-PAGE)
biological sourcehuman
formaqueous solution
Gene Informationhuman ... ATXN3(4287)
mol wt42 kDa
NCBI accession no.NM_004993
packagingpkg of 250 µg
recombinantexpressed in E. coli
shipped indry ice
storage temp.−70°C
UniProt accession no.P54252
This product has met the following criteria: